Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2B histone pseudogene 9 (H2BP9) is a processed pseudogene located in the human genome similar in sequence to histone H2B genes but contains specific nucleotide changes that prevent the expression of a functional H2B protein[7]. Such pseudogenes often arise by duplication or retrotransposition of functional genes but acquire mutations that render them inactive. The altered coding sequence typically includes frameshift mutations, missing regulatory elements, or disruptive changes in essential residues, as described for the H2B pseudogene in human histone clusters. H2BP9 does not contribute to nucleosome formation, chromatin compaction, or DNA regulation, which are central functions of the canonical histone H2B proteins[1][4]. Pseudogenes may occasionally be transcribed and can participate in regulatory networks, but there is no documented biological activity or disease association reported for H2BP9.
None (no drugs targeting this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2B histone pseudogene 9 (H2BP9).